LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 39 filers reported holding LUMOS PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,059 | 0.0% | 10,927 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $36,059 | -0.3% | 10,927 | 0.0% | 0.01% | -7.7% |
Q1 2023 | $36,168 | -62.6% | 10,927 | 0.0% | 0.01% | -71.7% |
Q4 2022 | $96,704 | -0.3% | 10,927 | 0.0% | 0.05% | 0.0% |
Q3 2022 | $97,000 | +15.5% | 10,927 | +0.1% | 0.05% | +2.2% |
Q2 2022 | $84,000 | – | 10,916 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 407,192 | $4,071,000 | 0.70% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 50,000 | $500,000 | 0.66% |
Opaleye Management Inc. | 382,000 | $3,820,000 | 0.63% |
Investors Financial Group, LLC | 29,600 | $296,000 | 0.16% |
Wealth Advisors of Iowa, LLC | 11,760 | $178,000 | 0.09% |
NEA Management Company, LLC | 526,663 | $5,267,000 | 0.07% |
Marquette Asset Management, LLC | 8,919 | $89,000 | 0.02% |
Blackstone Inc. | 468,145 | $4,681,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 52,543 | $522,000 | 0.01% |
Jefferies Group LLC | 120,651 | $1,206,510 | 0.01% |